Sept. 27, 2010
Genzyme, the largest biotech company in the Boston-area, has been hit by hard times recently. A virus contaminated the biotech giant's Allston plant and resulted in a $175 million fine from the FDA. Now, a French drug company is interested in purchasing Genzyme. Business contributor Kris Frieswick joins Emily to gauge the impact this is having on Genzyme and biotech in Boston.